Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (39) , 11016-26
Abstract
Antibody-mediated rejection (AMR) caused by donor-specific anti-human leukocyte antigen antibodies (DSA) is widely accepted to be a risk factor for decreased graft survival after kidney transplantation. This entity also plays a pathogenic role in other solid organ transplants as it appears to be an increasingly common cause of heart graft dysfunction and an emerging issue in lung transplantation. In contrast, the liver appears relatively resistant to DSA-mediated injury. This “immune-tolerance” liver property has been sustained by a low rate of liver graft loss in patients with preformed DSA and by the intrinsic liver characteristics that favor the absorption and elimination of DSA; however, alloantibody-mediated adverse consequences are increasingly being recognized, and several cases of acute AMR after ABO-compatible liver transplant (LT) have been reported. Furthermore, the availability of new solid-phase assays, allowing the detection of low titers of DSA and the refinement of objective diagnostic criteria for AMR in solid organ transplants and particularly in LT, have improved the recognition and management of this entity. A cost-effective strategy of DSA monitoring, avoidance of class II human leukocyte antigen mismatching, judicious immunosuppression attached to a higher level of clinical suspicion of AMR, particularly in cases unresponsive to conventional anti-rejection therapy, can allow a rational approach to this threat.Keywords
This publication has 107 references indexed in Scilit:
- Liver transplantation with a strongly positive crossmatch: Case study and literature reviewLiver Transplantation, 2013
- Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantationLiver Transplantation, 2013
- Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 DiabetesJournal of Diabetes Research, 2013
- Treatment options and strategies for antibody mediated rejection after renal transplantationSeminars in Immunology, 2012
- The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver TransplantationAmerican Journal of Transplantation, 2011
- Pre- and posttransplantation allosensitization in heart allograft recipients: Major impact of de novo alloantibody production on allograft survivalHuman Immunology, 2011
- Human leukocyte antigen crossmatch testing is important for liver retransplantationLiver Transplantation, 2010
- Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell helpClinical and Experimental Immunology, 2009
- Graft fibrosis after pediatric liver transplantationHepatology, 2009
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993